Gladstone NOW: The Campaign Join Us on the Journey ✕
61 - 75 of 101 Results Clear All
France 24—On France 24, Gladstone President Deepak Srivastava explains CRISPR technology and the potential is has to cure disease.
Gladstone Experts Srivastava Lab
Funds will support five top research institutions to accelerate scientific discoveries and development of treatments for single ventricle heart defects.
Grants News Release Cardiovascular Disease Data Science and Biotechnology Bruneau Lab Pollard Lab Srivastava Lab
Bloomberg Law—Gladstone President Deepak Srivastava comments in Bloomberg Law on the Trump Administration’s plan to implement a fetal tissue ethics review board. Srivastava states that a once-a-year review board will hold up important medical research.
Gladstone Experts Srivastava Lab
Gladstone started as a single institute in 1979 but has since grown to four institutes which use cutting-edge technology to tackle cardiovascular, neurological, and immunological diseases.
History Cardiovascular Disease Data Science and Biotechnology Neurological Disease Infectious Disease Greene Lab Mahley Lab Mucke Lab Pollard Lab Srivastava Lab
Team of six laboratories will combine expertise in heart development and -omics technology to probe genome activity and organization in heart cells.
Grants News Release Heart Failure Bruneau Lab Conklin Lab Krogan Lab Pollard Lab Srivastava Lab
Gladstone began as a single entity with a single purpose. But as the scientists followed the science—unencumbered by the red tape of bureaucracy—the purpose, and the focus, grew.
History Institutional News Neurological Disease Cardiovascular Disease Data Science and Biotechnology Infectious Disease Finkbeiner Lab Greene Lab Mahley Lab Mucke Lab
Gladstone prepares for the future of discovery science with the launch of new strategic plan.
Office of the President History Institutional News Srivastava Lab
The Washington Post—Gladstone President Deepak Srivastava comments in the Washington Post on a new study that debunks controversial stem cell procedures.
Gladstone Experts Srivastava Lab
Since Shinya Yamanaka discovered a method to create human induced pluripotent stem (iPS) cells, Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.
Research (Publication) Stem Cell Core Alzheimer’s Disease Huntington’s Disease Finkbeiner Lab Huang Lab McDevitt Lab Srivastava Lab Yamanaka Lab CRISPR/Gene Editing
Gladstone scientists gain important insights into the cellular reprogramming process
News Release Research (Publication) Heart Failure Cardiovascular Disease Pollard Lab Srivastava Lab Big Data Stem Cells/iPSCs
Gladstone scientists reveal how gene mutations can alter small groups of cells and result in congenital heart disease
News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Srivastava Lab Single Cell
A fan of science since she was a child—and today a Zumba aficionado too—Yvanka would like to meet Albert Einstein’s first wife to warn her about the impact of her marriage on her career.
Postdoctoral and Graduate Student Education and Research Development Affairs Graduate Students and Postdocs Profile Cardiovascular Disease Srivastava Lab
Research study first to show a heart defect caused by three genes acting together
News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Srivastava Lab CRISPR/Gene Editing Stem Cells/iPSCs
A look at the distinct eras defined by Gladstone’s three presidents
History Institutional News Mahley Lab Srivastava Lab
The path to medical breakthroughs lies in bold, ambitious science
Donor Stories Institutional News Spinal Cord Injuries Alzheimer’s Disease Diabetes Roddenberry Stem Cell Center Bruneau Lab Ding Lab Huang Lab McDevitt Lab
